Interleukin-6 as an adipokine and myokine: The regulatory role of cytokine in adipose tissue and skeletal muscle metabolism

Human Movement

Volumn 13, Issue 4, 2012, Pages 372-379

  Lutosławska, Grazyna ^a  

^a JÓZEF PI SUDSKI UNIVERSITY OF PHYSICAL EDUCATION IN WARSAW   (Poland)

Author keywords

Adipose tissue; Exercise; Interleukin 6; Skeletal muscle

Indexed keywords

EID: 84877946810     PISSN: 17323991     EISSN: 18991955     Source Type: Journal    
DOI: 10.2478/v10038-012-0045-y     Document Type: Article

References (97)

1. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Müller-Newen G., Schaper F., Principles of interleukin (IL)-6-type cytokine signaling and its regulation. Biochem J, 2003, 374, 1-20, doi: 10.1042/BJ2003.0407.
2. Simpson R.J., Hammacher A., Smith D.K., Matthews J.M., Ward L., Interleukin-6: Structure-function relationship. Protein Sci, 1997, 6, 929-955, doi: 10.1002/pro.5560060501.
3. Kishimoto T., Akira S., Narazaki M., Taga T., Interleukin-6 family of cytokines and gp130. Blood, 1995, 86, 1243-1254.
4. Kimamura D., Ishihara K., Hirano T., IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol, 2003, 149, 1-38, doi: 10.1007/s10254-003-0012-2.
5. Kishimoto T., Hibi M., Murakami M., Narazaki M., Saito M., Taga T., The molecular biology of interleukin-6 and its receptor. Ciba Found Symp, 1992, 167, 5-16.
6. Fonseca-Alaniz M.H., Takada J., Alonso-Vale M.I., Lima F.B., Adipose tissue as an endocrine organ: from theory to practice. J Pediatr, 2007, 83 (5 Suppl.), S192-S203, doi: 10.2223/JPED.1709.
7. Deng Y., Scherer P., Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann NY Acad Sci, 2010,1212, E1-E19, doi: 10.1111/j.1749-6632.2010.05875.x.
8. Mohamed-Ali V., Goodrick S., Rawesh A., Katz D.R., Miles J.M., Yudkin J.S., Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-, in vivo. J Clin Endocrinol Metab, 1997, 82, 4196-4200, doi: 10.1210/jc.82.12.4196.
9. Vozarova B., Weyer Ch., Hanson K., Tataranni P.A., Bogardus C., Pratley R.E., Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res, 2001, 9, 414-417, doi: 10.1038/oby.2001.54.
10. Maachi M., Pièroni L., Bruckert E., Jardel C., Fellahi S., Hainque B., Systemic low-grade inflammation is related to both circulating and adipose tissue TNF-, leptin and IL-6 levels in obese women. Int J Obes, 2004, 28, 993-997, doi: 10.1038/sj.ijo.0802718.
11. Cartier A., Lemieux I., Almèras N., Tremblay A., Bergeron J., Desprès J.-P., Visceral obesity and plasma glucoseinsulin homeostasis: contribution on interleukin and tumor necrosis factor-in men. J Clin Endocrinol Metab, 2008, 93, 1931-1938, doi: 10.12/jc.2007-2191.
12. Bastrad J.P., Jardel C., Bruckert E., Blondy P., Capeau J., Laville M., Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab, 2000, 85, 3338-3342, doi: 10.1210.jc.85.9.3338.
13. Ryan A.S., Nicklas B.J., Reduction in plasma cytokine levels with weight loss improves insulin sensitivity in overweight and obese postmenopausal women. Diabetes Care, 2004, 27, 1699-1705, doi: 10.2337/diacare.27.7.1699.
14. Moschen A.R., Molnar C., Geiger S., Graziadel I., Ebenbichler C.F., Weiss H., Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumor necrosis factor alpha expression. Gut, 2010, 59, 1259-1264, doi: gut.2010.214577v1.
15. Oberhauser F., Schulte D.M., Faust M., Güdelhöfer H., Hahn M., Müller N., Weight loss due to very low calorie diet differentially affects insulin sensitivity and interleukin-6 serum levels in non-diabetic obese human subjects. Horm Metab Res, 2012, 44, 465-470, doi: 10.1055/s-0032.13066341.
16. Wallenius V., Wallenius K., Aren B., Rudling M., Carlsten H., Dickson S.L., Interleukin-6-deficient mice develop mature-onset obesity. Nat Med, 2002, 8, 75-79, doi: 10.1038/nm0102-75.
17. Tsigos C., Papanicolaou D.A., Kyrou I., Defensor R., Mitsiadis C.S., Chrousos G.P., Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab, 1997, 82, 4167-4170, doi: 10.1012/jc.82.124167.
18. Fernandez-Real J.M., Vayreda M., Richart C., Gutierrez C., Broch M., Vendrell J., Rickart W., Circulating interleukin-6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab, 2001, 86, 1154-1159, doi: 10.1012/jc.86.3.1154.
19. Senn J.J., Klover P.J., Nowak I.A., Mooney R.A., Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes, 2002, 51, 3391-3399, doi: 10.2337.51.12.3391.
20. Klover P.J., Zimmers T.A., Koniaris L.G., Mooney R.A., Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes, 2003, 52, 2784-2789, doi: 10.2337/diabetes.52.11.2784.
21. Rotter V., Nagaev I., Smith U., Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem, 2003, 278, 45777-45784, doi: 10.1074/jbc.M301977200.
22. Kern P.A., Ranganathan S., Li C., Wood L., Ranganathan G., Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab, 2001, 280, E745-R751. Available from: URL: http://www.ajpendo.org
23. Rotter Sopasakis V., Larsson B.M., Johansson A., Holmäng A., Smith U., Short-term infusion of interleukin-6 does not induce insulin resistance in vivo or impair insulin signaling in rats. Diabetologia, 2004, 47, 1879-1887, doi: 10.1007/s00125-004-1554y.
24. Franckhauser S., Elias I., Rotter Sopasakis V., Ferrè T., Nagaev I., Andersson C.X., Overexpression of IL-6 leads to hyperinsulinaemia, liver inflammation and reduced body weight. Diabetologia, 2008, 51, 1306-1316, doi: 10.1007/s00125-008-0998-8.
25. Carey A.L., Syeinberg G.R., Macaulay S.L., Thomas W.G., Holmes A.G., Ramm G., Interleukin-6 increases insulinstimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes Care, 2006, 55, 2688-2697, doi: 10.2337/db05-1404.
26. Holmes A.G., Mesa J.L., Neill B.A., Chung J., Carey A.L., Steinberg G.R., Prolonged interleukin-6 administration enhances glucose tolerance and increases skeletal muscle PPAR and UCP2 expression in rats. J Endocrinol, 2008, 198, 367-374, doi: 10,1677/JOE-08-0113.
27. Ruge T., Lockton J.A., Renstrom F., Lystig T., Sukonina V., Svensson M.K., Eriksson J.W., Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index. Metabolism, 2009, 58, 860-866.
28. Ruotsalainen E., Stancáková A., Vauhkonen I., Salmienniemi U., Pihlajamäki J., Punnonen K., Changes in cytokine levels during acute hyperinsulinemia in offspring of type 2 diabetic subjects. Atherosclerosis, 2010, 210, 536-541.
29. Lyngsø D., Simonsen L., Bülow J., Metabolic effects of interleukin-6 in human splanchnic and adipose tissue. J Physiol, 2004, 543, 379-386, doi: 10.1113/lphysiol.2002. 021022.
30. van Hall G., Steensberg A., Sachcetti M., Fischer Ch., Keller Ch., Schjerling P., Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab, 2003, 88, 3005-3010, doi: 10.1012/jc.2002.-021687.
31. Petersen W.W., Carey A.L., Sacchetti M., Steinberg G.R., Macaulay S.L., Febrraio M.A., Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture. Am J Physiol Endocrinol Metab, 2004, 288, E155-E162, doi: 10.1152/ajpendo.00257.2004.
32. Ji Ch., Chen X., Gao Ch., Jiao L., Wang J., Xu G., IL-6 induces lipolysis and mitochondrial dysfunction, but does not affect insulin-mediated glucose transport in 3T3-L1 adipocytes. J Bioenerg Biomembr, 2011, 43, 367-375, doi: 10.1007/s10863-011-9361-8.
33. Hiscock N., Fischer C.P., Sacchetti M., van Hall G., Febrraio M.A., Pedersen B.K., Recombinant human interleukin-6 infusion during low-intensity exercise does not enhance whole body lipolysis or fat oxidation in humans. Am J Physiol Endocrinol Metab, 2005, 289, E2-E7, doi: 10.1152/ajpendo.00274.2004.
34. Rotter Sopasakis V., Sandquvist M., Gustafson B., Hammerstedt A., Schmelz M., Yang X., High local concentrations and effects on a differentiation implicate interleukin-6 as a paracrine regulator. Obes Res, 2004, 12, 454-461, doi: 10.1038/oby.2004.51.
35. Engeli S., Feldpausch M., Gorzelniak K., Hartwig F., Heintze U., Janke J., Association between adiponectin and mediators of inflammation in obese women. Diabetes, 2003, 52, 942-947, doi: 10.2337.52.4.942.
36. Sopasakis V.R., Nagaev I., Smith U., Cytokine release from adipose tissue of nonobese individuals. Int J Obes, 2005, 29, 1144-1147, doi: 10.1038.sj.ijo.0803002.
37. Kralisch S., Klein J., Lossner U., Bluher M., Paschke R., Stumvoll M., Fasshauer M., Interleukin is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab, 2005, 289, E586-E590, doi: 10.1152/ajpendo.00090.2005.
38. Vázquez-Vale M.E.F., Torres N., Tovar A.R., White adipose tissue as endocrine organ and its role in obesity. Arch Med Res, 2008, 39, 715-728, doi: 10.1016/j.arcmed.2008.09.005.
39. Brandt C., Jakobsen A.H., Adser H., Olssen J., Iversen N., Kristensen J.M., IL-6 regulates exercise and training adaptation in subcutaneous adipose tissue in mice. Acta Physiol (Oxf), 2012, 205, 224-235, doi: 10.1111/j.1748-1716.2011.02.373.x.
40. Mohamed-Ali V., Flower L., Sethi J., Hotamisligil G., Gray R., Humpheries S.E., β-adrenergic regulation of IL-6 release from adipose tissue: in vivo and in vitro studies. J Clin Endocrinol Metab, 2001, 86, 5864-5869, doi: 10.1210/jc.86.12.5864.
41. Vicennati V., Vottero A., Friedman C., Papanicolaou D.A., Hormonal regulation of IL-6 production in human adipocytes. Int J Obes, 2002, 26, 905-911, doi: 10.1038/sj.ijo.0002035.
42. Fasshauer M., Klein J., Lossner U., Pasche R., Interleukin (IL)-6 mRNA expression is simulated by insulin, isoproterenol, tumor necrosis factor alpha, growth hormone, and IL-6 in 3T3-L1 adipocytes. Horm Metab Res, 2003, 35, 147-152, doi: 10.1055/S-2003-39075.
43. Keller P., Keller Ch., Robinson L.E., Pedersen B.K., Epinephrine infusion increases interleukin-6 gene expression and systemic levels in humans. J Appl Physiol, 2004, 97, 1309-1312, doi: 10.1152/japplphysiol.00284.2004.
44. Borcherding D.C., Hugo E.R., Idelman G., De Silva A., Richtand N.W., Loftus J., Dopamine receptors in human adipocytes: expression and functions. PloS One, 2011, 6, e25537. Available from: URL: http://www.plos.org
45. Roth S.M., Schrager M.A., Lee M.R., Lee M.R., Metter E.J., Hurley B.F., Interleukin-6 (IL-6) genotype is associated with fat-free mass in men but not women. J Gerontol A Biol Sci Med Sci, 2003, 58, B1085-1088, doi: 10.1093/gerona/58.12.B1085.
46. Calder P.C., Albers R., Antoine J.M., Blum S., Bourdet-Sicard R., Ferns G.A., Inflammatory disease processes and interactions with nutrition. Br J Nutr, 2009, 101 (Suppl. 1), S1-S45.
47. Janssen I., Ross R., Linking age-related changes in skeletal muscle mass and composition with metabolism and disease. J Nutr Health Aging, 2005, 9, 408-419.
48. Pedersen B.K., Muscles and their myokines. J Exp Biol, 2011, 214, 337-346, doi: 10.1242/jeb.048074.
49. Pedersen B.K., Steensberg A., Fischer C., Keller P., Plomgaard P., Wolsk-Petersen E., The metabolic role of IL-6 produced during exercise: is IL-6 an exercise factor? Proc Nutr Soc, 2004, 63, 263-267, doi: 10.1079/PNS2004338.
50. Ostrowski K., Hermann C., Bangash A., Schjerling P., Nielsen J.N., Pedersen B.K., A trauma-like elevation of plasma cytokines in humans in response to treadmill running. J Physiol, 1998, 513, 889-894, doi: 10.111/j.1469-7793. 1998.889ba.x.
51. Ostrowski K., Rohde T., Zacho M., Asp S., Pedersen B.K., Evidence that interleukin-6 is produced in human skeletal muscle during prolonged exercise. J Physiol, 1998, 508, 949-953, doi: 10.111/j.1469-7793.1998.949bp.x.
52. Jonsdottir I.H., Schjerling P., Ostrowski K., Asp S., Richter E.A., Pedersen B.K., Muscle contractions induce interleukin-6 mRNA production in skeletal muscle. J Physiol, 2000, 528, 157-163, doi: 10.1111/j.1469-7793.2000. 00157.x.
53. Starkie R.L., Rolland J., Angus D.J., Andersen M.J., Febrraio M., Circulating monocytes are not the source of elevation in plasma IL-6 and TNF-concentrations after prolonged exercise. Am J Physiol Cell Physiol, 2001, 280, C769-C774. Available from: URL: http://www.ajpcell.org.
54. Hiscock N., Chan M.H., Bisucci T., Darby I.A., Febrraio M.A., Skeletal myocytes are a source of interleukin-6 mRNA expression and protein release during contraction: evidence of fiber specificity. FASEB J, 2004, 18, 992-994, doi: 10.1096/fj.03-1259fje.
55. Keller Ch., Steensberg A., Hansen A.K., Fischer Ch., Plomgaard P., Pedersen B.K., Effect of exercise, training, and glycogen availability on IL-6 receptor expression in human skeletal muscle. J Appl Physiol, 2005, 90, 2075-2079, doi: 10.1152/japplphysiol.00590.2005.
56. Steensberg A., Febrraio M.A., Osada T., Schjerling P., van Hall G., Saltin B., Interleukin-6 production in contracting skeletal muscle is influenced by pre-exercise muscle glycogen content. J Physiol, 2001, 537, 633-639, doi: 10.1111/j.1469-7793.2001.00633.x.
57. Starkie R.L., Arkinstall M.J., Koukoulas I., Hawley J.A., Febrraio M.A., Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans. J Physiol, 2001,533,585-591, doi: 10.1111/j.1469-7793.2001.0585a.x.
58. Nieman D.C., Davis J.M., Henson D.A., Walberg-Rankin J., Shute M., Dumke C.L. et al., Carbohydrate ingestion influences skeletal muscle cytokine mRNA and plasma cytokine levels after a 3-h run. J Appl Physiol, 2003, 94, 1917-1925, doi: 10.1152/jaapplphysiol.01130.
59. Nieman D.C., Davis J.M., Henson D.A., Gross S.J., Dumke C.L., Utter A.C., Muscle cytokine mRNA changes after 2.5 h cycling: influence of carbohydrate. Med Sci Sports Exerc, 2005, 37, 1283-1290.
60. Robson-Ansley P., Barwood M., Eglin C., Ansley L., The effect of carbohydrate ingestion on the interleukin-6 response to a 90-minute run time trial. Int J Sports Physiol Perform, 2009, 4, 186-194.
61. Langberg H., Olesen J.I., Gemmer C., Kjaer M., Substantial elevation of interleukin-6 concentration in peritendious tissue, in contrast to muscle, following prolonged exercise in humans. J Physiol, 2002, 542, 985-990, doi: 10.1113/jphysiol.2002.019141.
62. Fischer Ch.P., Interleukin-6 in acute exercise and training: what is the biological relevance? Exerc Immunol Rev, 2006, 12, 6-33.
63. Febbraio M.A., Pedersen B.K., Muscle-derived interleukin-6: mechanism for activation and possible biological roles. FASEB J, 2002, 16, 1335-1347, doi: 10.1096/fj.01-0876rev.
64. Holmes A.G., Watt M.J., Febbraio M.A., Suppressing lipolysis increases interleukin-6 at rest and during prolonged exercise in humans. J Appl Physiol, 2004, 97, 689-696, doi: 10.1152/japplphysiol.00195.2004.
65. Ives S.J., Blegen M., Coughlin M.A., Redmond J., Matthews Y., Paolone V., Salivary estradiol, interleukin-6 production, and the relationship to substrate metabolism during exercise in females. Eur J Appl Physiol, 2011, 111, 1649-1658, doi: 10.1007/s00421-010-1789-8.
66. Bruce C.R., Dyck D.J., Cytokines regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-. Am J Physiol Endocrinol Metab, 2004, 287, E616-E621, doi: 10.1152/ajpendo.00150.2004.
67. Chabowski A., Zmijewska M., Gorski J, Bonen A., Kaminski K., Kozuch M., IL-6 deficiency increases fatty amid transporters and intramuscular lipid content in red but not white skeletal muscle. J Physiol Pharmacol, 2008, 59 (Suppl. 7), 105-117. Available from: URL: http://www.jpp.krakow.pl
68. Wolsk E., Mygind H., Grøndahl T.S., Pedersen B.K., van Hall G., IL-6 selectively stimulates fat metabolism in human skeletal muscle. Am J Physiol Endocrinol Metab, 2010, 299, E832-E840, doi: 10.1152/ajpendo.00328.2010.
69. Febbraio M.A., Hiscock N., Sacchetti M., Fischer Ch.P., Pedersen B.K., Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction. Diabetes, 2004, 53, 1643-1648, doi: 10.2337/diabetes.53.7. 1643.
70. Andreozzi F., Laratta E., Cardellini M., Marini M.A., Lauro R., Hribal M.L., Plasma interleukin-6 levels are independently associated with insulin secretion in a cohort of Italian-Caucasian nondiabetic subjects. Diabetes, 2006, 55, 2021-2024, doi: 10.2337/db06-0063.
71. Glund S., Deshmukh A., Long Y.Ch., Moller T., Koistinen H.A., Caidahl K., Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle. Diabetes, 2007, 56, 1630-1637, doi: 10.2337/db06-1733.
72. Geiger P.C., Hancock Ch., Wright D.C., Han D.-H., Holloszy J.O., IL-6 increases muscle insulin sensitivity only at supraphysiological levels. Am J Physiol Endocrinol Metab, 2007, 292, E1842-E1846, doi:10.1152/ajpendo.00701. 2006.
73. Holmes A.G., Mesa J.L., Neill B.A., Chung J., Carey A.L., Steinberg G.R., Prolonged interleukin-6 administration enhances glucose tolerance and increases skeletal muscle PPAR and UPC2 expression in rats. J Endocrinol, 2008, 198, 367-374, doi: 10.1677/JOE-08-0113.
74. Kelly M., Keller Ch., Avilucea P.R., Keller P., Luo Z., Xiang X., AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise. Biochem Biophys Res Commun, 2004, 320, 449-454, doi: 10.1016/j.bbrc.2004.05.188
75. Ruderman N.B., Keller Ch., Richard A.-M., Saha A.S., Luo Z., Xiang X., Interleukin-6 regulation of AMP-activated protein kinase. Potential role in the systemic response to exercise and prevention in the metabolic syndrome. Diabetes, 2006, 55 (Suppl. 2), S48-S54, doi: 10.2337/db06-S007.
76. Petersen A.M.W., Pedersen B.K., The role of IL-6 in mediating the anti-inflammatory effects of exercise. J Physiol Pharmacol, 2006, 57 (Suppl. 10), 43-51. Available from: URL: http://www.jpp.krakow.pl
77. Trayhurn P., Drevon C.A., Eckel J., Secreted proteins from adipose tissue and skeletal muscle - adipokines, myokines and adipose/muscle cross-talk. Acta Physiol Biochem, 2011, 117, 47-56, doi: 10.3109/13813455.2010.535835.
78. Ispirlidis I., Fatouros I.G., Jamurtas A.Z., Nikolaidis M.G., Michailidis I., Douroudos I., Time-course of changes in inflammatory and performance responses following a soccer game. Clin J Sport Med, 2008, 18, 423-431.
79. Robson-Ansley P., Barwood M., Canavan J., Hack S., Eglin C., Davey S., Hewitt J., The effect of repeated endurance exercise on IL-6 and sIL-6R and their relationship with sensations of fatigue at rest. Cytokine, 2009, 45, 111-116.
80. Fischer Ch., Plomgaard P., Hansen A.K., Pilegaard H., Saltin B., Pedersen B.K., Endurance training reduced the contraction-induced interleukin-6 mRNA expression in human skeletal muscle. Am J Physiol Endocrinol Metab, 2004, 287, E1189-E1194, doi: 10.1152/ajpendo.00206.2004.
81. Croft L., Bartlett J.D., MacLaren D.P., Reilly T., Evans L., Mattey D.L., High-intensity interval training attenuates the exercise-induced increase in plasma IL-6 response to acute exercise. Appl Physiol Nutr Metab, 2009, 34, 1098-1107, doi: 10.1139/H09-117.
82. Phillips M.D., Flynn M.G., McFarlin B.K., Stewart L.K., Timmerman K.L., Resistance training at eigth-repetition maximum reduces the inflammatory milieu in elderly men. Med Sci Sports Exerc, 2010, 42, 314-325, doi: 10.1249/MSS.0b013e3181b11ab7.
83. Thompson D., Markovitch D., Betts J.A., Mazzatti D., Turner J., Tyrrell R.M., Time course of changes in inflammatory markers during a 6-mo exercise intervention in sedentary middle-aged man: a randomized-controlled trial. J Appl Physiol, 2010, 108, 769-779, doi: 10.1152/japplphysiol.00822.2009.
84. Libardi C.A., De Souza G.V., Cavaglieri C.R., Madruga V.A., Chacon-Mikahil M.P., Effect of resistance, endurance, and concurrent training on TNF-, IL-6 and CR P. Med Sci Sports Exerc, 2012, 44, 50-56, doi: 10.1249/MSS.0b013e3182399dcc.
85. Polak J., Klimcakova E., Moro C., Viguerie N., Berlan M., Hejnova J., Effect of aerobic training on plasma levels and subcutaneous abdominal adipose tissue gene expression of adiponectin, leptin, interleukin-6 and tumor necrosis factor in obese women. Metabolism, 2006, 55, 1375-1381, doi: 10.1016/j.metabol.2006.06.008.
86. Oberbach A., Lehman S., Kirsch K., Kirst J., Sonnabend M., Linke A., Long-term exercise training decreases interleukin-6 (IL-6) serum levels in subjects with impaired glucose tolerance: effect of the - 174G/C variant in IL-6 gene. Eur J Endocrinol, 2008, 159, 129-136, doi: 10.1530/EJE-08-0220.
87. Akerstrom T.C.A., Krogh-Madsen R., Winther Petersen A.M., Pedersen B.K., Glucose ingestion during endurance training in men attenuates expression of myokine receptor. Exp Physiol, 2009, 94, 1124-1131, doi: 10.1113/expphysiol. 2009.048983.
88. Tsujinaka T., Fujita J., Ebisui Ch., Yano M., Kominami E., Suzuki K., Interleukin-6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. J Clin Invest, 1996, 97, 244-249, doi: 10.1172/JCI118398.
89. Kami K., Morikawa Y., Sekimoto M., Senba E., Gene expression of receptors for IL-6, LIF, and CNTF in regenerating skeletal muscle. J Histochem Cytochem, 2000, 48, 1203-1213, doi: 10.1177/002215540004800904.
90. Carson J.A., Baltgalvis K.A., Interleukin-6 as a key regulator of muscle mass during cachexia. Exerc Sport Sci Rev, 2010, 38, 168-176, doi: 10.1097/JES.0bo13e3181f44f11.
91. Bodell P.W., Kodesh E., Haddad F., Zaldivar F.P., Cooper D.M., Adams G.R., Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exercise. J Appl Physiol, 2009, 106, 443-453, doi: 10.1152/japplphysiol.90831.2008.
92. Serrano A.L., Baeza-Raja B., Perdiguero E., Jardi M., Muňoz-Cánoves P., Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metabolism, 2008, 7, 33-44, doi: 10.1016/j.cmet.2007.11.011.
93. McKay B.R., De Lisio M., Johnston A.P., O'Reilly C.E., Phillips S.M., Tarnopolsky M.A., Association of interleukin-6 signaling with the muscle stem cell response following muscle-lengthening contractions in humans. PLoS One, 2009, 24, e6027. Available from: URL: http://www. plosone.org
94. Toth K.G., McKay B.R., De Lisio M., Little J.P., Tarnopolsky M.A., Parise G., IL-6 induced STAT3 signaling is associated with the proliferation of human muscle satellite cells following acute muscle damage. PLos One, 2011, 6, e17392. Available from: URL: http://www.plosone. org
95. White U.A., Stephens J.M., The gp130 receptor cytokine family: regulators of adipocyte development and function. Curr Pharm Des, 2011, 17, 340-346, doi: 10.2174/1381612117951642002.
96. Broholm Ch., Mortensen O.H., Nielsen S., Akerstrom T., Zankari A., Dahl B., Exercise induces expression of leukaemia inhibitory factor in human skeletal muscle. J Physiol, 2008, 586, 2195-2201, doi: 10.1113/jphysiol. 2007.149781.
97. Brandt C., Pedersen B.K., The role of exercise-induced myokines in muscle homeostasis and the defense against chronic disease. J Biomed Biotech, 2010, doi: 10.1115/2010/520258.